Overview

Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris

Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
Multi-center, double-blind, randomized, placebo-controlled trial of Dapsone 5.0% Gel in the treatment of acne vulgaris.
Phase:
Phase 3
Details
Lead Sponsor:
Seegpharm S.A.
Treatments:
Dapsone